Plasma-lyte 148: Clinical Trials

1 trial of Plasma-lyte 148, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Plasma-lyte 148: new trials by email Literature Review of Plasma-lyte 148 trials Research Report on Plasma-lyte 148

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)
Human umbilical cord derived CD362 enriched MSCs, Placebo (Plasma-Lyte 148) - Acute Respiratory Distress Syndrome
Phase 1 / Phase 2Active not recruitingBelfast Health and Social Care Trust1292019-01-072025-09-08

Conditions studied

COVID-19 (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

Belfast Health and Social Care Trust (1)

Countries

United Kingdom (1)

Top investigators

Danny F McAuley, Professor (1)

Results publications

PMID 32493473, PMID 34746723, PMID 35562778, PMID 37154608